Publications

Found 593 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2017
Lin H, Magrane J, Rattelle A, Stepanova A, Galkin A, Clark EM, Dong YNa, Halawani SM, Lynch DR.  2017.  Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia.. Dis Model Mech. 10(11):1343-1352.
Lin H, Magrane J, Clark EM, Halawani SM, Warren N, Rattelle A, Lynch DR.  2017.  Early VGLUT1-specific parallel fiber synaptic deficits and dysregulated cerebellar circuit in the KIKO mouse model of Friedreich ataxia.. Dis Model Mech. 10(12):1529-1538.
Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..  2017.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.
Lee D, Lee W-S, Lim S, Kim YKyung, Jung H-Y, Das S, Lee J, Luo W, Kim K-T, Chung S-K.  2017.  A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer's phenotypes.. Sci Rep. 7(1):14125.
Kim E, Yang J, Park KWoo, Cho S.  2017.  Inhibition of VEGF Signaling Reduces Diabetes-Exacerbated Brain Swelling, but Not Infarct Size, in Large Cerebral Infarction in Mice.. Transl Stroke Res.
Reznik ME, Merkler AE, Mahta A, Murthy SB, Claassen J, Kamel H.  2017.  Long-term risk of seizures in adult survivors of sepsis.. Neurology. 89(14):1476-1482.
Cole DC, Chung Y, Gagnidze K, Hajdarovic KH, Rayon-Estrada V, Harjanto D, Bigio B, Gal-Toth J, Milner TA, McEwen BS et al..  2017.  Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.. Proc Natl Acad Sci U S A. 114(50):13272-13277.
Cole DC, Chung Y, Gagnidze K, Hajdarovic KH, Rayon-Estrada V, Harjanto D, Bigio B, Gal-Toth J, Milner TA, McEwen BS et al..  2017.  Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.. Proc Natl Acad Sci U S A. 114(50):13272-13277.
Glusman G, Rose PW, Prlić A, Dougherty J, Duarte JM, Hoffman AS, Barton GJ, Bendixen E, Bergquist T, Bock C et al..  2017.  Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework.. Genome Med. 9(1):113.
Glusman G, Rose PW, Prlić A, Dougherty J, Duarte JM, Hoffman AS, Barton GJ, Bendixen E, Bergquist T, Bock C et al..  2017.  Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework.. Genome Med. 9(1):113.
Akimova D, Wlodarczyk BJ, Lin Y, M Ross E, Finnell RH, Chen Q, Gross SS.  2017.  Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.. Birth Defects Res. 109(2):106-119.
O'Hara NB, Reed HJ, Afshinnekoo E, Harvin D, Caplan N, Rosen G, Frye B, Woloszynek S, Ounit R, Levy S et al..  2017.  Metagenomic characterization of ambulances across the USA.. Microbiome. 5(1):125.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..  2017.  Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..  2017.  Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Elsaid MFawzi, Chalhoub N, Ben-Omran T, Kumar P, Kamel H, Ibrahim K, Mohamoud Y, Al-Dous E, Al-Azwani I, Malek JA et al..  2017.  Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia.. Ann Neurol. 81(1):68-78.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..  2017.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..  2017.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..  2017.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..  2017.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.
Castro-Wallace SL, Chiu CY, John KK, Stahl SE, Rubins KH, McIntyre ABR, Dworkin JP, Lupisella ML, Smith DJ, Botkin DJ et al..  2017.  Nanopore DNA Sequencing and Genome Assembly on the International Space Station.. Sci Rep. 7(1):18022.
Castro-Wallace SL, Chiu CY, John KK, Stahl SE, Rubins KH, McIntyre ABR, Dworkin JP, Lupisella ML, Smith DJ, Botkin DJ et al..  2017.  Nanopore DNA Sequencing and Genome Assembly on the International Space Station.. Sci Rep. 7(1):18022.
Gasser PJ, Hurley MM, Chan J, Pickel VM.  2017.  Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice.. Brain Struct Funct. 222(4):1913-1928.
Sansone P, Savini C, Kurelac I, Chang Q, Amato LBenedetta, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly L et al..  2017.  Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.. Proc Natl Acad Sci U S A. 114(43):E9066-E9075.
Sansone P, Savini C, Kurelac I, Chang Q, Amato LBenedetta, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly L et al..  2017.  Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.. Proc Natl Acad Sci U S A. 114(43):E9066-E9075.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..  2017.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.